These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 28245322)

  • 21. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
    Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML
    J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Douketis JD; Berger PB; Dunn AS; Jaffer AK; Spyropoulos AC; Becker RC; Ansell J
    Chest; 2008 Jun; 133(6 Suppl):299S-339S. PubMed ID: 18574269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of upper gastrointestinal bleeding with low-dose acetylsalicylic acid alone and in combination with clopidogrel and other medications.
    García Rodríguez LA; Lin KJ; Hernández-Díaz S; Johansson S
    Circulation; 2011 Mar; 123(10):1108-15. PubMed ID: 21357821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of antithrombotic agents on recurrence rate and clinical outcome in patients operated for chronic subdural hematoma.
    Abboud T; Dührsen L; Gibbert C; Westphal M; Martens T
    Neurocirugia (Astur : Engl Ed); 2018; 29(2):86-92. PubMed ID: 29122534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcomes after traumatic brain injury in elderly patients on antithrombotic therapy.
    Laic RAG; Verhamme P; Vander Sloten J; Depreitere B
    Acta Neurochir (Wien); 2023 May; 165(5):1297-1307. PubMed ID: 36971847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
    Abdul-Jawad Altisent O; Durand E; Muñoz-García AJ; Nombela-Franco L; Cheema A; Kefer J; Gutierrez E; Benítez LM; Amat-Santos IJ; Serra V; Eltchaninoff H; Alnasser SM; Elízaga J; Dager A; García Del Blanco B; Ortas-Nadal Mdel R; Marsal JR; Campelo-Parada F; Regueiro A; Del Trigo M; Dumont E; Puri R; Rodés-Cabau J
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1706-17. PubMed ID: 27539691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of recurrent venous thromboembolism after discontinuation of vitamin K antagonist treatment: a nested case-control study.
    Martinez C; Katholing A; Folkerts K; Cohen AT
    J Thromb Haemost; 2016 Jul; 14(7):1374-83. PubMed ID: 27079164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes.
    Lopes RD; Li L; Granger CB; Wang TY; Foody JM; Funk M; Peterson ED; Alexander KP
    Am J Med; 2012 Sep; 125(9):897-905. PubMed ID: 22795814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of wound hematoma at carotid endarterectomy under dual antiplatelet therapy.
    Oldag A; Schreiber S; Schreiber S; Heinze HJ; Meyer F; Weber M; Halloul Z; Goertler M
    Langenbecks Arch Surg; 2012 Dec; 397(8):1275-82. PubMed ID: 22677970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombocytopenia, dual antiplatelet therapy, and heparin bridging strategy increase pocket hematoma complications in patients undergoing cardiac rhythm device implantation.
    Chen HC; Chen YL; Guo BF; Tsai TH; Chang JP; Pan KL; Lin YS; Chen MC
    Can J Cardiol; 2013 Sep; 29(9):1110-7. PubMed ID: 23474139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiplatelet drugs and risk of subarachnoid hemorrhage: a population-based case-control study.
    Schmidt M; Johansen MB; Lash TL; Christiansen CF; Christensen S; Sørensen HT
    J Thromb Haemost; 2010 Jul; 8(7):1468-74. PubMed ID: 20345728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
    You JJ; Singer DE; Howard PA; Lane DA; Eckman MH; Fang MC; Hylek EM; Schulman S; Go AS; Hughes M; Spencer FA; Manning WJ; Halperin JL; Lip GYH
    Chest; 2012 Feb; 141(2 Suppl):e531S-e575S. PubMed ID: 22315271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bleeding complications of triple antithrombotic therapy after percutaneous coronary interventions.
    Faza NN; Mentias A; Parashar A; Chaudhury P; Barakat AF; Agarwal S; Wayangankar S; Ellis SG; Murat Tuzcu E; Kapadia SR
    Catheter Cardiovasc Interv; 2017 Feb; 89(2):E64-E74. PubMed ID: 27220088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of oral antiplatelet therapy on hemorrhagic complications of pacemaker implantation.
    Said SM; Esperer HD; Hahn J; Bollmann A; Richter S; Rauwolf T; Prondzinsky R; Schmeisser A; Braun-Dullaeus RC
    Clin Res Cardiol; 2013 May; 102(5):345-9. PubMed ID: 23386254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials?
    Duerschmied D; Brachmann J; Darius H; Frey N; Katus HA; Rottbauer W; Schäfer A; Thiele H; Bode C; Zeymer U
    Clin Res Cardiol; 2018 Jul; 107(7):533-538. PubMed ID: 29679144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents.
    Choi HI; Ahn JM; Kang SH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    JACC Cardiovasc Interv; 2017 Jun; 10(11):1075-1085. PubMed ID: 28527773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Illustration of the impact of antiplatelet drugs on the genesis and management of chronic subdural hematoma.
    Mascarenhas L
    Neurochirurgie; 2012 Feb; 58(1):47-51. PubMed ID: 22030168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aspirin therapy and risk of subdural hematoma: meta-analysis of randomized clinical trials.
    Connolly BJ; Pearce LA; Kurth T; Kase CS; Hart RG
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):444-8. PubMed ID: 23422345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aspirin Use and Risk of Subdural Hematoma: Updated Meta-Analysis of Randomized Trials.
    Hart RG; Pearce LA; Gorelick PB; Connolly BJ; Catanese L
    J Stroke Cerebrovasc Dis; 2021 Aug; 30(8):105911. PubMed ID: 34130102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of Antiplatelet and Anticoagulant Drug Use on Outcomes after Chronic Subdural Hematoma Drainage.
    Poon MTC; Rea C; Kolias AG; Brennan PM;
    J Neurotrauma; 2021 Apr; 38(8):1177-1184. PubMed ID: 30526281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.